Previously, the results of our clinical study have suggested that circadian rhythm have an impact on neurological outcomes following cardiac arrest and cardiopulmonary resuscitation (CA/CPR), but the underlying mechanisms remain unknown. Here, using a mouse model of CA/CPR, we aimed to unravel the underlying mechanisms of the diurnal variation in CA/CPR-induced brain injury. The mice received 5 min of CA either in the active phase or in the inactive phase. To identify novel therapeutic targets for the impact of circadian rhythm on CA/CPR-induced brain injury, we applied high throughput RNA-seq analysis to profile mRNAs with differentially expression in the hippocampus of the two groups. Since it has been reported that CMKLR1 is beneficial for inhibiting neuroinflammation and improving neurological outcomes among many neurological diseases, we centered on this gene and clarified that its main cellular source is microglia. The correlation between CMKLR1 expression in hippocampus and neurological outcomes after CA/CPR was elucidated by CMKLR1 activation and knockout in microglia. The impact of CMKLR1 on microglial function, especially glucose metabolism, was clarified using BV2 microglia cell line by glucose uptake analysis, seahorse analysis and carbon 13 tracing. As a result, CA/CPR happening at active phase leads to better neurological outcomes with upregulation of microglial CMKLR1 in the hippocampus of mice. Our findings suggest that elevated microglial CMKLR1 expression in the hippocampus contributes to improved neurological outcomes after CA/CPR by promoting lactate production in microglia.